Barings LLC Bei Gene, Ltd. Transaction History

Barings LLC

$4.05 Billion
Q4 2024

A detailed history of Barings LLC transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Barings LLC holds 71,422 shares of BGNE stock, worth $16.2 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

71,422

Previous 67,998 5.04%

Holding current value

$16.2 Million

Previous $15.3 Million 13.59%

% of portfolio

0.33%

Previous 0.38%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	BUY	$174.72 - $246.04 $598,241 - $842,440	3,424 Added 5.04%	71,422 $13.2 Million
Q3 2024 Nov 13, 2024	BUY	$143.93 - $224.51 $2.34 Million - $3.64 Million	16,235 Added 31.36%	67,998 $15.3 Million
Q2 2024 Aug 08, 2024	BUY	$129.52 - $174.32 $2.68 Million - $3.6 Million	20,663 Added 66.44%	51,763 $7.39 Million
Q1 2024 May 08, 2024	SELL	$141.8 - $181.47 $4.15 Million - $5.31 Million	-29,279 Reduced 48.49%	31,100 $4.86 Million
Q4 2023 Feb 08, 2024	BUY	$158.67 - $201.58 $9.58 Million - $12.2 Million	60,379 New	60,379 $10.9 Million
Q4 2021 Feb 09, 2022	SELL	$248.56 - $389.34 $229,669 - $359,750	-924 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$249.6 - $403.14 $230,630 - $372,501	924 New	924 $335,000
Q1 2020 May 15, 2020	SELL	$121.84 - $173.19 $2.17 Million - $3.09 Million	-17,842 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$115.78 - $208.34 $100,960 - $181,672	-872 Reduced 4.66%	17,842 $2.96 Million
Q3 2019 Nov 13, 2019	SELL	$120.61 - $148.29 $5.4 Million - $6.64 Million	-44,767 Reduced 70.52%	18,714 $2.29 Million
Q2 2019 Aug 12, 2019	SELL	$113.99 - $146.86 $34,766 - $44,792	-305 Reduced 0.48%	63,481 $7.87 Million
Q1 2019 May 08, 2019	SELL	$122.82 - $151.83 $8.15 Million - $10.1 Million	-66,385 Reduced 51.0%	63,786 $8.42 Million
Q4 2018 Feb 07, 2019	BUY	$107.01 - $175.15 $3.42 Million - $5.59 Million	31,915 Added 32.48%	130,171 $18.3 Million
Q3 2018 Oct 26, 2018	SELL	$152.62 - $189.66 $8.34 Million - $10.4 Million	-54,648 Reduced 35.74%	98,256 $16.9 Million
Q2 2018 Aug 03, 2018	BUY	$152.5 - $216.77 $6.08 Million - $8.64 Million	39,848 Added 35.25%	152,904 $23.5 Million
Q1 2018 May 04, 2018	BUY	$97.41 - $177.22 $11 Million - $20 Million	113,056 New	113,056 $19 Million

Others Institutions Holding BGNE

# of Institutions

249

Shares Held

45.4M

Call Options Held

292K

Put Options Held

114K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $23.5B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Barings LLC with notifications on news.

Account